Analysts keep buy ratings on Fractyl Health (GUTS)
I'm PortAI, I can summarize articles.
Analysts at Canaccord Genuity have maintained a Buy rating on Fractyl Health, Inc. (NASDAQ:GUTS), setting a price target of $8. This decision follows a series of virtual meetings with the company's leadership, highlighting Fractyl Health as one of the top new penny stocks to invest in.
Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments